Penn Medicine Translational
Neuroscience Center (PTNC)

Funding Opportunities, Courses, etc.

(Note: these lists are updated regularly so check back often)




The purpose of the American Heart Association/Allen Initiative in Brain Health and Cognitive Impairment is to discover and fund highly promising teams of investigators who can expand the frontiers of bioscience, pursuing creative, transformative ideas with the potential to move brain health and cognitive impairment science forward. Paul G. Allen Frontiers Group and the American Heart Association/American Stroke Association are committing $43 million with additional partners to co-fund a new research initiative with the goal of shedding new light on how to better prevent, detect, and treat age-related cognitive impairment, including Alzheimer's disease.

The AHA and Paul G. Allen Frontiers Group, with additional funding contributors including the Oskar Fischer Project, will grant a competitive basic science research award(s) of up to $43 million over eight years to one or more highly inspiring and innovative integrated team(s). New frontiers of discovery in brain health, and more specifically in cognitive impairment, will be opened when expertise and novel advances are shared and leveraged among basic and clinical cerebrovascular scientists and neuroscientists. Such integrative studies have the potential to bring truly novel directions of inquiry to the current incremental progress in the field of neurodegeneration and Alzheimer’s Disease research, with potentially exponential or transformational new insights.

Link to full RFP
Applications open in Grants@Heart: Monday, May 21, 2018
Application Deadline: Friday, July 6, 2018


The National Multiple Sclerosis Society mobilizes people and resources to drive research on a cure for and to address the challenges of everyone affected by MS. The society currently is accepting applications for its Pilot Grant Program, which provides grants to quickly test novel ideas that may serve to advance its mission of stopping MS progression, restore function, improve quality of life, and/or prevent MS. The program supports fundamental as well as applied studies, non-clinical or clinical in nature, including projects in patient management, care, and rehabilitation.

Through the program, one-year grants of up to $55,000 will be awarded in support of innovative, cutting-edge ideas or untested methods, and to gather sufficient preliminary data to apply for longer-term funding.

Researchers who have completed their postdoctoral training are invited to apply. Individuals who are currently postdoctoral fellows or the equivalent, or who are graduate/medical students are not eligible for support under this program.

Link to the Full RFP
Deadlines: September 12 (pre-application is due September 10).


Alzheimer's Drug Discovery Foundation Issues RFP for Preclinical Drug Discovery Program

The ADDF's Drug Discovery RFP focuses on supporting programs that aim to:

  1. Advance novel lead molecules to the clinical candidate selection stage (defined as compounds suitable for IND-enabling studies); or
  2. Build preclinical evidence in relevant animal models for repurposed/repositioned drugs

See the RFP for additional information related to funding priorities.

Average Project Length: One year with potential for follow-on funding. Multi-year proposals can be considered.
Average Award: $150,000-$600,000 based on stage and scope of research. For studies requiring additional support, co-funding from other funding agencies or investors is encouraged.

Upcoming Deadlines: Letter of Intent, July 13, 2018/Invited Full Proposal, August 10, 2018; Letter of Intent, October 12, 2018/Invited Full Proposal, November 9, 2018


The Michael J. Fox Foundations seeks pre-proposals for research into:

  • Role of alpha-synuclein and modified forms in health and disease 
  • Relationship between alpha-synuclein structure and physiological functions 
  • Novel therapeutic approaches targeting intracellular alpha-synuclein or related pathways 

The Foundation also is accepting pre-proposals for projects in GBA; non-pharmacological interventions for gait and balance; and protein handling, exosome and lipidomic biomarkers.

Pre-proposals due May 31. Click here for more information.


The Michael J. Fox Foundations seeks pre-proposals for Funding for Gait and Balance Interventions.

The Michael J. Fox Foundation will award one-to-two-year grants to test non-pharmacological interventions for the treatment of gait and balance disturbances in people with Parkinson’s disease (PD). We are particularly interested in proof-of-concept, validation and data-analysis projects.

The Michael J. Fox Foundation is seeking pre-proposals investigating the therapeutic benefit of:

  • Assistive devices 
  • Novel technologies 
  • Rehabilitative therapy programs 

Please note this program is not appropriate for cognitive strategies and exercise programs.

Pre-proposals due May 31. Click here for more information.


Vilcek Foundation Invites Applications for Creative Promise Prizes in Biomedical Science

The Vilcek Foundation aims to raise public awareness of the contributions of immigrants to the sciences, arts, and culture in the United States. To that end, the foundation will award Vilcek Prizes for Creative Promise in Biomedical Science of $50,000 to three young foreign-born biomedical scientists who demonstrate outstanding early achievement. The work of applicants may be in basic, applied, and/or translational biomedical science.

To be eligible, applicants must have been born outside the United States, and must not be more than 38 years old as of December 31, 2018. Eligible applicants also must be a naturalized citizen, permanent resident (green card holder), or holder of an H1B or O-1 visa who has been living and working in the United States for at least five years, or who has been granted Deferred Action for Childhood Arrivals (DACA) status.

In addition, applicants must have earned a doctoral degree (MD, PhD, or equivalent), intend to pursue a professional career in the United States, and hold a full-time position at an academic institution or other organization. Eligible positions include assistant or associate professor, research scientist, or equivalent.

Deadline: June 11, 2018


2018-2019 Oklahoma Nathan Shock Center Pilot Project Awards

The Oklahoma Nathan Shock Center is soliciting applications to support the research of junior investigators developing R01 applications and senior investigators developing new applications to the NIH in the Biology of Aging.

The projects should utilize one or more of the four Cores of the Center, which provides services that can be used to analyze biological samples from humans to invertebrates: Multiplexing Protein Quantification Core, Targeted DNA Methylation & Mitochondrial Heteroplasmy Core, Integrative Redox Biology Core and the Discovery Bioinformatics Core. Prior consultation with the Core Directors is strongly advised.

The awards are for 1 year and are generally between $10,000 and $20,000 depending on the specific needs of the applicant. Applications from institutions outside of the University of Oklahoma Health Sciences Center are strongly encouraged.

Click here for Pilot Award Flyer

Applications Due June 1



NIH BRAIN Initiative Active Funding —

Private Foundation Funding —

NIH Funding Opportunities —

NSF Funding Opportunities —





Additional Funding Opportunities can be found at the following links:

Perelman School of Medicine funding opportunities page

ITMAT funding opportunities page





News & Announcements

Highlighted Events

More events